Sustaining Corporate Growth in a Rapidly Changing Industry

Originally Published September 1999

COVER STORY

Greg Freiherr

Corporate growth is the highest priority for Ronald Dollens. Through in-house R&D, licensing, and acquisitions, Dollens has put together a technological juggernaut at Guidant Corp. (Indianapolis) that produces a variety of devices for cardiovascular therapy.

Last year, Guidant recorded nearly $1.9 billion in sales, an increase of 43% over the previous year. Its 1998 net income of $359.4 million was an 82% increase from 1997.